Tous Actualités
Suivre
Abonner Balda AG

Balda AG

EANS-News: Balda AG
Medical subsidiary obtains regulatory approval for an innovative product under its own name for the first time

Bad Oeynhausen (euro adhoc) -

  Corporate news transmitted by euro adhoc. The issuer/originator is solely
  responsible for the content of this announcement.
New Products
Balda AG: Medical subsidiary obtains
regulatory approval for an innovative product under its own name for 
the first time
Successful system integration of hardware and software for a unique
pharmaceutical dispenser
Bad Oeynhausen, 6 October 2010 - Balda Medical GmbH & Co. KG, Bad 
Oeynhausen, an affiliated company of Balda AG listed on the SDax on 
the Frankfurt Stock Exchange, has successfully completed the 
development of an innovative product on behalf of a global 
pharmaceutical client. "The device supports the effect of the 
medicine by timely, precise and regular use. This unique 
pharmaceutical dispenser combines both mechanical components and 
electronic assistance systems in one. We are responsible for both, 
the complete implementation of hardware as well as software", 
explains Dr. Rolf Eilers, CEO of Balda Medical. In addition, the 
company satisfies all regulatory requirements. Balda Medical has 
obtained the regulatory approval for the pharmaceutical dispenser 
under its own name for the first time for the European market 
(CE-symbol). The core business of the company, based in Bad 
Oeynhausen, comprises the development, the set up for mass production
and the production of disposable articles as well as complex products
manufactured from plastic. The main customer base comes from the 
pharmaceuticals, diagnostics and medical technology market segments.
The product, which is also intended for the U.S. market, was 
developed in accordance with the requirements of the U.S. Food and 
Drug Administration (FDA). Balda Medical will provide comprehensive 
product documentation for the approval procedure, called "Device 
Master File". The company has been registered as a manufacturer by 
the FDA since 2009.
With the new drug dispenser Balda Medical is following important 
market trends in two ways. The rapidly increasing self-care of 
patients with hand-held devices occurs more frequently now using 
electronic support. The appropriate and controlled intake of medicine
allows for a significantly improved treatment of patients.
The successful system integration of software and hardware, as well 
as the lead responsibility for regulatory requirements, demonstrates 
the broad service portfolio and the competitive strengths of the 
system partner Balda Medical. "The demand from our customers for a 
variety of capabilities from one source is constantly increasing," 
said Eilers.
  • * * Company Profile Balda AG The Balda Group develops and produces complete plastic assemblies, electronic products and products for the medical industry. The customers of Balda are leaders in business from the mobile, entertainment and electronic communications as well as pharmaceutical and medical technology markets. The group has an international position with product sites in China, Malaysia and Germany. A subsidiary in the United States serves North American customers in product design and development. As part of a shareholding in a leading manufacturer of touch screens in China, Balda participates in the dynamic touch screen displays market.
  • * *
This corporate news announcement includes "forward-looking 
statements" which are based on the current expectations of the 
management of Balda. They are subject to risks and uncertainty 
because they relate to events and depend on circumstances that will 
occur in the future, such as, for example, developments in the mobile
communications industry, changes in technology and the ability to 
timely and successfully develop new products and various other 
factors. Balda does not undertake any obligation to update publicly 
or revise forward-looking statements except to the extent legally 
required. This corporate news announcement is not an offer of 
securities for sale or a solicitation of an offer to purchase 
securities in the United States or elsewhere. The shares in Balda AG 
(the "Shares") may not be offered or sold in the United States or to 
or for the account or benefit of U.S. persons (as such term is 
defined in Regulation S under the U.S. Securities Act of 1933, as 
amended (the "Securities Act") unless registered under the Securities
Act or pursuant to an exemption from such registration. The Shares 
have not been and will not be registered under the Securities Act.
end of announcement                               euro adhoc

Further inquiry note:

Clas Röhl
Tel.: +49 (0) 5734 922-2728
croehl@balda.de

Branche: Semiconductors & active components
ISIN: DE0005215107
WKN: 521510
Index: CDAX, Prime All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Hamburg / free trade
Stuttgart / free trade
Düsseldorf / free trade
München / free trade

Plus de actualités: Balda AG
Plus de actualités: Balda AG
  • 30.09.2010 – 10:22

    EANS-News: Balda AG / with new major shareholder (with document)

    Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Company Information Bad Oeynhausen (euro adhoc) - Balda AG with new major shareholder Bad Oeynhausen, 30 September 2010 - Balda AG, listed on the SDax of the Frankfurt stock exchange, has a new shareholder. Die Senrigan Capital Group Limited based in Hong Kong holds 5,34 percent of the ...

  • 12.08.2010 – 15:43

    EANS-News: Balda AG / wins Samsung as a new customer

    Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Company Information Bad Oeynhausen (euro adhoc) - Balda AG wins Samsung as a new customer Production starts in August and will reach high volume by early 2011 Bad Oeynhausen, 12 August 2010 - The MobileCom division of Balda AG, listed in the SDax of the Frankfurt Stock Exchange, has won ...

  • 05.08.2010 – 08:15

    EANS-News: Balda AG on the move (with document)

    First half-year 2010: Earnings up in the second quarter / operational result still in the red / differing development in the segments / forecast 2010 affirmed Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. 6-month report Subtitle: First half-year 2010: Earnings up in the second quarter / operational result still in the red / ...